Lv1
24 积分 2026-01-09 加入
Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial
4天前
已完结
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials
4天前
已完结
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
4天前
已完结
A Phase I Study to Evaluate the Safety and Pharmacokinetics of SHR0302 Base Ointment in Healthy Adult Volunteers
2个月前
已完结
Effect of SHR0302 on the pharmacokinetics of CYP3A4, CYP2C8, CYP2C9 and CYP2C19 probe substrates in healthy volunteers: A cocktail analysis
2个月前
已完结
Effect of CYP3A4 induction and inhibition on the pharmacokinetics of SHR0302 in healthy subjects
2个月前
已完结
Quantification of SHR0302 in human plasma by UPLC-MS/MS and application to a pharmacokinetic study
2个月前
已完结
Atopic Dermatitis
2个月前
已完结
Treatment of Atopic Dermatitis
2个月前
已完结
皖公网安备34019202002308
